Page 6 - Haematologica Vol. 110 - January 2025

Perspective Articles
Articles
37 T-cell clones of uncertain significance. When is the rogue clone dangerous? G. Semenzato et al.
https://doi.org/10.3324/haematol.2024.286023
Acute Lymphoblastic Leukemia
47 Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial
K.A. Thus et al.
https://doi.org/10.3324/haematol.2024.285428
Acute Lymphoblastic Leukemia
55 Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study
D. Lazzarotto et al.
https://doi.org/10.3324/haematol.2024.285638
Acute Myeloid Leukemia
68 Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study
D. Niederwieser et al.
https://doi.org/10.3324/haematol.2024.285879
Chronic Lymphocytic Leukemia
78 LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia
J. Ravikrishnan et al.
https://doi.org/10.3324/haematol.2023.284353
Chronic Lymphocytic Leukemia
92 Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial
N.N. Shah et al.
https://doi.org/10.3324/haematol.2024.285754
Chronic Myeloid Leukemia
103 Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia
M. Minhajuddin et al.
https://doi.org/10.3324/haematol.2023.284716
Chronic Myeloid Leukemia
117 Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia
H. Komic et al.
https://doi.org/10.3324/haematol.2024.285071
Non-Hodgkin Lymphoma
129 Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets P. Stephan et al.
https://doi.org/10.3324/haematol.2023.284448
Non-Hodgkin Lymphoma
142 Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
T. Othman et al.
https://doi.org/10.3324/haematol.2024.285185
Haematologica | 110 January 2025
II